Publication

RNA polymerase III limits longevity downstream of TORC1

Filer, D., Thompson, M. A., Takhaveev, V., Dobson, A. J., Kotronaki, I., Green, J. W. M., Heinemann, M., Tullet, J. M. A. & Alic, N., 14-Dec-2017, In : Nature. 552, 7684, p. 263-267 16 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • RNA polymerase III limits longevity downstream of TORC1

    Final publisher's version, 3.91 MB, PDF document

    Request copy

DOI

Three distinct RNA polymerases transcribe different classes of genes in the eukaryotic nucleus(1). RNA polymerase (Pol) III is the essential, evolutionarily conserved enzyme that generates short, non-coding RNAs, including tRNAs and 5S rRNA(2). The historical focus on transcription of protein-coding genes has left the roles of Pol III in organismal physiology relatively unexplored. Target of rapamycin kinase complex 1 (TORC1) regulates Pol III activity, and is also an important determinant of longevity(3). This raises the possibility that Pol III is involved in ageing. Here we show that Pol III limits lifespan downstream of TORC1. We find that a reduction in Pol III extends chronological lifespan in yeast and organismal lifespan in worms and flies. Inhibiting the activity of Pol III in the gut of adult worms or flies is sufficient to extend lifespan; in flies, longevity can be achieved by Pol III inhibition specifically in intestinal stem cells. The longevity phenotype is associated with amelioration of age-related gut pathology and functional decline, dampened protein synthesis and increased tolerance of proteostatic stress. Pol III acts on lifespan downstream of TORC1, and limiting Pol III activity in the adult gut achieves the full longevity benefit of systemic TORC1 inhibition. Hence, Pol III is a pivotal mediator of this key nutrient-signalling network for longevity; the growth-promoting anabolic activity of Pol III mediates the acceleration of ageing by TORC1. The evolutionary conservation of Pol III affirms its potential as a therapeutic target.

Original languageEnglish
Pages (from-to)263-267
Number of pages16
JournalNature
Volume552
Issue number7684
Early online date29-Nov-2017
Publication statusPublished - 14-Dec-2017

    Keywords

  • MICROFLUIDIC DISSECTION PLATFORM, LIFE-SPAN EXTENSION, DROSOPHILA-MELANOGASTER, BUDDING YEAST, C-ELEGANS, RAPAMYCIN, EXPRESSION, TRANSCRIPTION, SYSTEM, CELLS

ID: 50695536